NCT02150369View on ClinicalTrials.gov

Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

February 16, 2015

Primary Completion Date

March 2, 2017

Study Completion Date

March 2, 2017

Conditions
Metastatic Renal Cell CarcinomaMetastatic MelanomaHigh-dose Interleukin-2
Trial Locations (1)

27710

Duke University Hospital, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER